IBL HealthCare Ltd

IBL HealthCare maintains a conservative capital structure with a debt-to-equity ratio of 0.07, significantly below the industry median for Drug Retailers. The company's liquidity position is mixed, with a current ratio of 2.02 but negative net cash after subtracting total debt. Free cash flow of PKR 197.25 million in the latest period suggests some operational flexibility, though operating cash flow was negative at PKR 259.67 million. Profitability metrics show a return on equity of 8.97% and return on assets of 5.2%, both below the industry median for Drug Retailers. The company's gross margin of 33.5% (calculated from gross profit of PKR 1.45 billion on revenue of PKR 4.32 billion) is in line with the sector average, but operating margin of 10.1% (PKR 437.3 million on revenue of PKR 4.32 billion) indicates pressure from operating expenses. The company's revenue is concentrated in a single business model focused on healthcare product distribution. No geographic breakdown is available in the input data, but the presence of a distribution warehouse in Karachi suggests regional concentration in Pakistan. The company operates as a subsidiary of The Searle Company Limited and International Brands Limited, which may provide supply chain and distribution advantages. Outlook data is not provided in the input, but the company's free cash flow and operating cash flow trends suggest mixed growth potential. The negative operating cash flow raises questions about the sustainability of current operations without external financing. The company's capital expenditure of PKR 19.15 million in the latest period indicates limited reinvestment in growth. Risk factors include medium liquidity risk due to negative net cash after debt and a low dilution risk score. The company has not issued additional shares recently, and no dilution sources are identified in the input data. The risk assessment flags net cash as negative after subtracting total debt, which could constrain operational flexibility. Recent events include the latest financial filing (HA-latest) and no disclosed earnings call transcripts. The company's financial snapshot provides a baseline for monitoring future performance, but no material events are reported in the input data.